File S1 - LIM Domain Only-2 (LMO2) Induces T-Cell Leukemia by Two Distinct Pathways

Supporting Information. Table S1. Taqman probes used for qRT-PCR. Table S2. Primers used for Notch1 mutational analysis. Table S3. Summary of Notch1 mutational analysis. Table S4. List of primers used in ChIP assay. Figure S1. Supervised clustering of human T-ALL based on LMO2. Figure S2. Supervised clustering of human T-ALL based on HHEX. Figure S3. Concordant expression of HHEX, LMO2, and MEF2C in primary T-ALLs. Figure S4. Survival analysis differs among CD2-Lmo2 transcriptional profiles. Figure S5. Crossing CD2-Lmo2 transgenics onto B6 increases T-ALL latency. Figure S6. Hhex conditional knockout alleles. Figure S7. Enhancer constructs analyzed in paper. Figure S8. ChIP-seq data from CCRF-CEM cells. (PDF)